Literature DB >> 11760862

Utilization of medical services and quality of life among low-income patients with generalized anxiety disorder attending primary care clinics.

G N Jones1, S C Ames, S K Jeffries, I C Scarinci, P J Brantley.   

Abstract

OBJECTIVE: Anxiety disorders appear to influence morbidity and medical utilization. However, little is known about the relationship between Generalized Anxiety Disorder, quality of life, and medical utilization, especially among low-income patients. The goals of this investigation were to 1) determine if low-income patients with GAD utilize medical services more than patients with other Axis I diagnoses, or no psychopathology, and 2) compare the health-related quality of life of these three groups.
METHOD: Participants were randomly recruited from public primary care clinics and administered intake assessments of demographics, stress, and health-related self-report questionnaires. At the end of the first year a structured psychiatric interview was administered (N = 431). Over the second year, patients (n = 360) were administered a health-related quality of life measure every three months for four assessments. Medical charts were abstracted to collect information about chronic illnesses and visits to outpatient clinics and the emergency department during the two years.
RESULTS: Patients were predominantly middle-aged, low-income, uninsured African-American females. In this low-income sample, patients with GAD utilized the emergency department more and reported poorer quality of life than patients with other Axis I disorders and patients without any psychopathology.
CONCLUSION: Low-income patients with GAD utilize the emergency department more and report poorer quality of life than patients with other Axis I disorders and patients without any psychopathology. Programs to identify and treat patients with GAD may yield improvements in quality of life, as well as reduce emergency department utilization.

Entities:  

Mesh:

Year:  2001        PMID: 11760862     DOI: 10.2190/2X44-CR14-YHJC-9EQ3

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  12 in total

1.  Human and economic burden of GAD, subthreshold GAD, and worry in a primary care sample.

Authors:  Sarah J Kertz; Janet Woodruff-Borden
Journal:  J Clin Psychol Med Settings       Date:  2011-09

2.  Impairment and functioning in a sample of primary care patients with generalized anxiety disorder: results from the primary care anxiety project.

Authors:  Risa B Weisberg; Courtney Beard; Maria E Pagano; Kristin M Maki; Larry Culpepper; Martin B Keller
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

3.  Psychological and pharmacological treatments for generalized anxiety disorder (GAD): a meta-analysis of randomized controlled trials.

Authors:  Emily Carl; Sara M Witcraft; Brooke Y Kauffman; Eilis M Gillespie; Eni S Becker; Pim Cuijpers; Michael Van Ameringen; Jasper A J Smits; Mark B Powers
Journal:  Cogn Behav Ther       Date:  2019-02-14

4.  Health-related quality of life across the anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions (NESARC).

Authors:  Jonathan S Comer; Carlos Blanco; Deborah S Hasin; Shang-Min Liu; Bridget F Grant; J Blake Turner; Mark Olfson
Journal:  J Clin Psychiatry       Date:  2010-08-24       Impact factor: 4.384

5.  Expectancy/Credibility Change as a Mediator of Cognitive Behavioral Therapy for Generalized Anxiety Disorder: Mechanism of Action or Proxy for Symptom Change?

Authors:  Michelle G Newman; Aaron J Fisher
Journal:  Int J Cogn Ther       Date:  2010-09

6.  Depression and anxiety diagnoses are not associated with delayed resolution of abnormal mammograms and pap tests among vulnerable women.

Authors:  Andrea C Kronman; Karen M Freund; Tim Heeren; Kristine A Beaver; Mary Flynn; Tracy A Battaglia
Journal:  J Gen Intern Med       Date:  2011-11-15       Impact factor: 5.128

7.  A preliminary study of psychiatric, familial, and medical characteristics of high-utilizing sickle cell disease patients.

Authors:  Patrick C Carroll; Carlton Haywood; Michelle R Hoot; Sophie Lanzkron
Journal:  Clin J Pain       Date:  2013-04       Impact factor: 3.442

8.  The burden of late-life generalized anxiety disorder: effects on disability, health-related quality of life, and healthcare utilization.

Authors:  Emily K Porensky; Mary Amanda Dew; Jordan F Karp; Elizabeth Skidmore; Bruce L Rollman; M Katherine Shear; Eric J Lenze
Journal:  Am J Geriatr Psychiatry       Date:  2009-06       Impact factor: 4.105

9.  Association of comorbid generalized anxiety disorder and alcohol use disorder symptoms with health-related quality of life: results from the National Epidemiological Survey on Alcohol and Related Conditions.

Authors:  Bernadette A Cullen; Lareina N La Flair; Carla L Storr; Kerry M Green; Anika A H Alvanzo; Ramin Mojtabai; Lauren R Pacek; Rosa M Crum
Journal:  J Addict Med       Date:  2013 Nov-Dec       Impact factor: 3.702

10.  Correlates of generalized anxiety disorder: independent of co-morbidity with depression: findings from the first Israeli National Health Interview Survey (2003-2004).

Authors:  Khitam Muhsen; Joshua Lipsitz; Noga Garty-Sandalon; Raz Gross; Manfred S Green
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-07-19       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.